When is the Late-breaking Abstract submission deadline?
The Late-breaking Abstract Center will close on July 16 at 8:00 pm CT.
How do I submit a Late-Breaking Abstract?
CNS Members: Log in to the abstract center using your CNS Account email and password. You may reset your password if you forgot it by clicking on “Forgot your password”. Please contact abstracts@cns.org if you need assistance with your login.
Non-members: If you have ever created a CNS non-member account, you may already have a username and password. Please try logging in with any possible email addresses that might have been used. If you forgot your password, use the Forgot Password link to reset it. If you are experiencing login issues with your CNS account or would like to verify your credentials, please contact abstracts@cns.org for assistance.
If you are not a member and have never used the abstract center before, you can create an account by clicking on the blue “Create an Account” button.
Can I submit more than one abstract?
There is no limit to the number of abstracts you may submit. All abstracts submitted must be original science, not previously presented as peer-reviewed original science at any other regional, national, or international scientific conference. Prior presentation by students/trainees at local research symposia is acceptable.
What are the presentation formats?
Oral Presentation or Digital Poster
The final abstract presentation format will be at the discretion of the Scientific Program Committee.
Oral Presentations are selected from the highest-ranked abstracts from each neurosurgical subspecialty for mini-podium presentation in scientific sessions.
Digital Posters are created in the CNS Digital Poster Center and are displayed electronically on multiple screens in the CNS Experience Lounge during open Exhibit Hall hours. Viewers can search by title, subject, or author to find a digital poster to view on the screen. There is no podium presentation associated with a digital poster presentation.
All abstracts that are accepted, regardless of format, will also be displayed continuously throughout the meeting as a Digital Poster, available for viewing on multiple screens in the CNS Experience Lounge during open Exhibit Hall hours Monday-Wednesday and after the Annual Meeting on the CNS website. Meeting participants have the opportunity to review copies of any poster at their convenience throughout the meeting. Your original abstract will be converted to a Digital Poster upon acceptance, and you will be able to edit and further enhance it before the Digital Poster deadline of October 20, 2026. Digital posters cannot be edited after the October 20, 2026, deadline.
How can I add authors?
Search the database for author names on the Authors tab. If the authors are not in the database, select “Add New Author.” Once the Late-breaking Abstract Center closes, you will not be able to add or delete authors.
What information is required?
-
-
- Title
- Abstract (300-word maximum) separated into:
- Introduction
- Methods
- Results
- Conclusion
- Disclosure of conflict of interest
Can I add images to my abstract?
Up to five images may be attached to your submission. Images cannot be in PDF format.
Are awards available for Late Breaking Abstracts?
There are no awards available for abstracts submitted to the Late Breaking Abstract Center.
Can I edit my abstract once it has been submitted?
Edits can be made until the Abstract Center submission deadline for Late Breaking Abstracts only. Edits can include changing the title, adding or deleting authors, or changing the abstract body for Late Breaking Abstracts only.
Who will review the abstracts?
All abstracts are blindly reviewed by a committee of qualified neurosurgeons.
When will I be notified of the results?
Notifications of the Abstract Selection Committee's decision will be sent in mid-August via email to the presenting author of all abstracts, regardless of the outcome. Presenting authors of accepted abstracts are required to register for the CNS Annual Meeting.
ACCME Guidelines for Compliance
Your abstract and/or poster will be reviewed for compliance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education.
Below are lists of guidelines to assist you in developing the highest quality educational content and materials. These guidelines also ensure compliance with the CNS’s CME Policies.
Before submitting to the 2026 CNS Annual Meeting Late Breaking Abstract Center, please review the following to ensure compliance.
You may be required to edit your submission if it is found to be noncompliant with these standards:
- ACCME and HIPAA Compliance - All individual identifiable health information regarding a client or patient must be sufficiently edited or modified to ensure HIPAA compliance.
- Standard 1: Ensure Content is Valid
- Presentations must give a balanced view of therapeutic options. All recommendations for patient care must be based on current science, evidence, and clinical reasoning.
- New and evolving topics must be clearly identified in the presentation slides.
- Standard 2: Prevent Commercial Bias and Marketing in Accredited Continuing Education
- Faculty must not promote or sell products or services that serve their professional or financial interest during accredited education.
- Presentations must be free of commercial bias for or against any company, product, drug, or device.
- Educational materials (slides, abstracts, handouts, videos, and photos) must not include:
- Ineligible companies’ corporate or product logos
- Company, product, drug, or device brand/trade names (Use generic names)
- If brand/trade names are listed, there MUST be at least two (2) other names listed to avoid the perception of bias.
- If only one is listed, it must be proven the ONLY or the BEST product, device, or drug available.
- All logos or brand names visible in photos or videos must be completely covered.
- Product promotional material
Clinical Neurosurgery
Abstracts selected for Oral Presentations, Mini Oral Posters, and awards are published in Clinical Neurosurgery. Figures, tables, videos, supplementary materials, reference citations and lists, honorary degrees, and international fellowship designations are removed prior to publication.
All abstracts are screened using software that detects prior publication. Abstracts previously published in whole or in part—either as abstracts or full-length manuscripts—or containing substantial duplicated text from existing publications will not be published in Clinical Neurosurgery.
Disclosures
Disclosure information will only be required of those whose abstracts are selected for presentation at the 2026 CNS Annual Meeting. Disclosures will not be required at the time of abstract submission.
The CNS is accredited by the Accreditation Council for Continuing Medical Education (ACCME). We appreciate your help in partnering with us to follow accreditation guidelines and help us create high-quality education independent of industry influence. To participate as a person in control of the educational content of this accredited CE activity, we ask that all invited planners, faculty, and speakers disclose all financial relationships with any ineligible companies* that you have had over the past 24 months.
ACCME Standards for Integrity and Independence in Accredited Continuing Education require providers to mitigate relevant financial relationships to prevent commercial bias and disclose the presence or absence of all relevant financial relationships to learners prior to the activity.
According to Standard 3.2 of the ACCME Standards for Integrity and Independence in Accredited Continuing Education, “Owners and employees of ineligible companies must be excluded from controlling content or participating as planners or faculty in accredited education”.
In compliance with the ACCME standards, please note the following CNS policies.
- The Presenting Author of any accepted abstract /poster cannot be employed by an ACCME-defined Ineligible Company*.
- Employees of commercial interests are prohibited from having any role in the planning or implementation of CME activities related to the Ineligible Company’s business lines or products.
*An ineligible company is any company whose primary business is producing, marketing, re-selling, or distributing health care products used by, on patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests. A commercial interest is not eligible for ACCME accreditation or participation in Joint Providership.
Content Without Commercial Bias
The CNS must ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. It is an ACCME requirement that audiences at educational programs for which continuing medical education hours are awarded be informed of a presenter’s academic and professional affiliations, and the existence of any significant financial interest or other relationship an author or co-author has with the manufacturer(s) of any commercial product(s) or services. Any such relationship must be disclosed.
In accordance with ACCME standards, please note that the presenter of any accepted abstract cannot be employed by a commercial interest. Employees of commercial interests are prohibited from having any role in the planning or implementation of CME activities related to the commercial interest’s business lines or products.